Prostate cancers are generally treatable with positive survival outcomes. However, following common treatments such as androgen receptor inhibitors, some prostate […]
A study from Nature Medicine has significantly refined the use of prostate-specific antigen (PSA) screening for prostate cancer using an […]
When used in combination with the standard prostate-specific antigen test for prostate cancer (PCa), a new epigenetic assay can improve […]
Written by Lauren Robertson, Science Writer New research suggests some prostate cancer drugs may change how certain prostate tumours function, […]
Written by Lauren Robertson, Science Writer As one of the leading causes of cancer-related deaths for men in the US […]
Written by Miyako Rogers, Science Writer In a new study published in Nature, researchers developed a large prostate cancer genomics […]
Scientists have discovered a molecular pathway that may answer why some prostate cancers can resist an approved cancer drug. The […]
Written by Charlotte Harrison, Science Writer Finding biomarkers in the urine of patients with aggressive prostate cancer would help identify […]
Written by Sharmin Begum, science writer Black patients who were diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), have been analysed […]
Researchers have explored the circadian clock and found an unexpected role for the clock gene CRY-1 in prostate cancer progression. […]
